Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-26 @ 12:46 AM
NCT ID:
NCT01349660
Group ID:
EG002
Title:
Phase II - (60 mg BKM120, 10mg/kg Bevacizumab)
Description:
BKM120: 60mg by mouth (PO), once a day for each 28 day cycle. Bevacizumab: 10 mg/kg administered intravenously (IV) on Day 1 and Day 15 of each 28 day cycle.
Phase II patients include those with progressive glioblastoma multiforme
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
27
Serious Number At Risk:
76
Other Number Affected:
75
Other Number At Risk:
76
Study:
NCT01349660
Results Section:
NCT01349660
Adverse Events Module:
NCT01349660